Financial Statements — EVOX
Balance Sheet
(in millions USD)| Metric | Q2
2026 | Q1
2026 |
|---|
| Cash & Equivalents | -- | 1.01 |
| Total Current Assets | -- | 1.15 |
| Total Non-current Assets* | -- | 243.37 |
| Total Assets | 0.26 | 244.52 |
| Accounts Payable | -- | 0.14 |
| Total Current Liabilities | 0.33 | 0.26 |
| Total Non-current Liabilities* | 0.00 | 9.60 |
| Total Liabilities* | 0.33 | 9.86 |
| Retained Earnings | (0.09) | (8.67) |
| Total Stockholder Equity | (0.07) | (8.67) |
* Derived from reported values
Income Statement
(in millions USD) (except per-share rows)| Metric | Q2
2026 | Q1
2026 |
|---|
| Selling, General & Admin | 0.09 | 0.17 |
| Operating Income | (0.09) | (0.17) |
| Net Income | (0.07) | 1.95 |
| Basic EPS | (0.01) | -- |
| Diluted EPS | (0.01) | -- |
Cash Flow Statement
(in thousands USD)| Metric | Q1
2026 |
|---|
| Operating Cash Flow | (109.83) |
